Home > Updates

Updates

Apr. 22, 2025: A commentary written by Ryoichi Maezono has been published in the Journal of Cellular Immunology.
Apr. 21, 2025: The review article written by Masahiko Ajiro , titled -Aberrant RNA splicing regulation as a novel source of neoantigens- has been published in Japanese Journal of Cancer and Chemotherapy.
Apr. 18, 2025: Congrats to Ryoichi Maenosono―he has received the General Assembly Award at the 112th Annual Meeting of the Japanese Urological Association!!
Apr. 15, 2025: Congrats to Masahiko Ajiro ― his co–first-authored paper just came out in Science Advances!
Apr. 1, 2025: Akihide Yoshimi’s project titled 'Verification of drug discovery targeting cancer-specific cell surface receptors' has been selected for the AMED FY2025 Drug Discovery Booster.
Apr. 1, 2025: Akihide Yoshimi has been appointed as a Collaborative Professor at the Graduate School of Medicine, the University of Tokyo.
Apr. 1, 2025: Tomoya Muto's project has been accepted for a JSPS KAKENHI Grant-in-Aid for Scientific Research (B)!
Apr. 1, 2025: Asuka Kawachi's project has been accepted for a JSPS KAKENHI Grant-in-Aid for Scientific Research (C)!
Apr. 1, 2025: Parihe Muhetaer joined our team as a researcher!
Apr. 1, 2025: Kenshiro Nishihara joined our team as a researcher!
Apr. 1, 2025: Nanami Yamano joined our team as an observership visitor!
Apr. 1, 2025: Sakura Inoue joined our team as an observership visitor!
Apr. 1, 2025: Lu Zhu joined our team as an observership visitor!
Mar. 20, 2025: The case report authored by Takuya Izumi has been accepted and is now in press in Annals of Hematology!
Mar. 18, 2025: Akihide Yoshimi’s project titled 'Establishment of Efficient Design Techniques for Splicing-Regulatory Nucleic Acid Therapeutics Using the hareCLIP Method' has been selected for the AMED FY2025 Drug
Mar. 18, 2025: Akihide Yoshimi’s project titled 'Identification and Validation of Drug Targets for Multiple Diseases and Conditions through the Development of a Novel Transcriptome Analysis Platform' has been selected for the AMED FY2025 Drug Discovery Infrastructure Advancement Research Program.
Mar. 15, 2025: Akihide Yoshimi served as the organizing committee chair and a speaker at the Cancer Research Symposium 2025.
Mar. 3, 2025: Mina Yoshida has been selected for the RNAJ Travel Fellowships by the Japan RNA Society!
Mar. 3, 2025: The joint research with the University of Electro-Communications (Atsuro Oishi and Akihide Yoshimi) has been published in the Nikkei newspaper.
Feb. 28, 2025: Akihide Yoshimi delivered an invited lecture at the 1st General Discussion Meeting of the mRNA Targeted Drug Discovery Research Organization on “Drug Discovery through Splicing Regulation.”
Feb. 27, 2025: Akihide Yoshimi delivered an invited talk at Tokyo Metropolitan Institute of Medical Science.
Feb. 20, 2025: Mina Yoshida has received the Director's Award from the research institute!
Feb. 18, 2025: Akihide Yoshimi delivered an invited talk at the 24th Core to Core Symposium “Hematopoiesis and Leukemia”.
Feb. 14, 2025: Rei Kudo gave an invited lecture at the Breast Cancer Expert Seminar!
Feb. 14, 2025: Atsuro Oishi and Akihide Yoshimi's research findings have been jointly press-released with the University of Electro-Communications.
Feb. 5, 2025: Akihide Yoshimi delivered an invited talk at the 13th AACR-JCA Joint Conference.
Jan. 4, 2025: Takuya Izumi and Akihide Yoshimi have contributed to the publication -The role of splicing factor mutations in hematologic malignancies and therapeutic targets-(in Japanese).
Dec. 19, 2024: Akihide Yoshimi delivered a talk at the Kyoto University NCC Satellite Campus Opening Commemorative Symposium!
Nov. 29, 2024: Mina Yoshida was awarded the MBSJ-EMBO Poster Award!
Nov. 29, 2024: Mina Yoshida gave an oral presentation on hareCLIP-seq at the symposium of the 47th Annual Meeting of the Molecular Biology Society of Japan!
Nov. 26, 2024: Mina Yoshida gave an invited talk on hareCLIP-seq at the Fukuoka RNA Club/ISFRCB2024!
Nov. 21, 2024: Hirotaka Matsui delivered a talk onDDX41 scRNA-seq at the 29th meeting of Hematological malignancy clinical study group!
Nov. 21, 2024: Mina Yoshida delivered a talk on hareCLIP-seq at the 29th meeting of Hematological malignancy clinical study group!
Nov. 9, 2024: Akihide Yoshimi has received the Excellence Award from the Japan Health Foundation!
Nov. 6, 2024: Tomoya Muto gave an invited lecture at the 97th Annual Meeting of the Japanese Biochemical Society!
Oct. 25, 2024: Our research proposal, Validation of the Target Suitability of Common Cancer Antigens for the Development of Cancer Prevention mRNA Vaccine has been selected for funding by AMED. PI: Akihide Yoshimi
Oct. 24, 2024: Kazuki Nishimura gave a talk on NECTIN4 at the 62nd Annual Meeting of Japan Society of Clinical Oncology!!
Oct. 21, 2024: Akihide Yoshimi gave a lecture at the LSBM Seminar at the University of Tokyo's Research Center for Advanced Science and Technology.
Oct. 15, 2024: Maiko Seki has joined as a master's student!
Oct. 13, 2024: Hirofumi Yamauchi gave an oral presentation on the B56a BRET sensor at the 86th Annual Meeting of the JSH!
Oct. 13, 2024: Mina Yoshida gave an oral presentation on hareCLIP-seq at the 86th Annual Meeting of the JSH!
Oct. 11, 2024: Rei Kudo's paper has been published in Cancer Cell!
Oct. 10, 2024: Asuka Kawachi was awarded an Encouraging Award from the Director Dr. Mano!
Oct. 7, 2024: We took a group photo of the lab!
Sep. 21, 2024: Ryoichi Maenosono received the 1st JCA-KFCR young research award at the 83rd JCA Annual Meeting!
Sep. 21, 2024: Rei Kudo, Ryoichi Maenosono and Hirofumi Yamauchi presented their posters at the 83nd JCA Annual Meeting.
Sep. 19, 2024: Mina Yoshida delivered a talk on hireCLIP-seq in the young plenary session at the 83nd JCA Annual Meeting.
Sep. 19, 2024: Asuka Kawachi delivered a talk on the RNA modification in the Symposium at the 83nd JCA Annual Meeting.
Sep. 18, 2024: Kazuki Nishimura's paper has been published in NPJ Precision Oncology!
Sep. 18, 2024: Our research proposal, -Precision stratified treatment based on individual differences due to retrotransposon-based insertion polymorphisms- has been chosen for funding by AMED. PI: Akihide Yoshimi
Sep. 15, 2024: Ryoichi Maenosono received the Chairman's Award at The 100th Annual Meeting for the Osaka Society for Dialysis Therapy!!
Sep. 14, 2024: Ryoichi Maenosono had an oral presentation at The 60th Annual Congress of the Japan Society for Transplantation!!
Sep. 1, 2024: Moritoshi Sakamoto joined our team as an observership visitor!
Aug. 30, 2024: Satoshi Kaito's paper has been published in Nature Communications!
Aug. 21, 2024: Masahiko Ajiro delivered an invited talk at the Okayama Cardiovascular Conference!!
Jul. 31, 2024: Rei Kudo's project, 'Preclinical Study of a Novel Nucleic Acid Medicine Therapy for Cancer,' has been selected for the Grant-in-Aid for Research Activity Start-up!
Jul. 29, 2024: Junko Mukohyama's paper has been published in Anticancer Research.
Jul. 12, 2024: Rei Kudo presented a poster at the 32nd Annual Meeting of the Japanese Breast Cancer Society.
Jul. 11, 2024: Ryoichi Maenosono had an oral presentation at the 28th Annual Meeting of Japanese Association of Cancer Immunology!!
Jul. 10, 2024: Masahiko Ajiro delivered an invited talk at the 28th Annual Meeting of Japanese Association of Cancer Immunology!!
Jun. 29, 2024: Minori Koizumi presented a poster at the 8th JCA-AACR Special Joint Conference.
Jun. 28, 2024: Mina Yoshida received the Excellence Award at the RNA meeting Japan!
Jun. 28, 2024: Ryoichi Maenosono had an oral presentation at the 67th Annual Meeting of the Japanese Society of Nephrology!!
Jun. 28, 2024: Mina Yoshida spoke at the 25th RNA2024 in Tokyo!!
Jun. 20, 2024: Asuka Kawachi spoke at Symposium 2 during the 28th Annual Meeting of the Japanese Association for Molecular Target Therapy of Cancer!!
Jun. 20, 2024: Akihide Yoshimi presented an invited lecture at the 28th Annual Meeting of the Japanese Association for Molecular Target Therapy of Cancer.
Jun. 14, 2024: Ryoichi Maenosono had an oral presentation at the 39th Japanese Society of Renal Transplantation and Vascular Surgery.
Jun. 11, 2024: Akihide Yoshimi's lecture at the 42nd Sapporo International Cancer Symposium was featured on NHK News!
Jun. 7, 2024: Ryoichi Maenosono had an oral presentation at the 69th Annual Meeting of the Japanese Society for Dialysis Therapy.
Jun. 7, 2024: Akihide Yoshimi delivered an invited talk at the 42nd Sapporo International Cancer Symposium.
Jun. 6, 2024: Our research proposal, Development of optimized nucleic acid therapeutics focusing on the RNA stability control of the sarcoma driver gene and analysis of pharmacokinetics has been chosen for funding by AMED. PI: Asuka Kawachi
Apr. 26, 2024: Ryoichi Maenosono had a poster presentation at the 111th Annual Meeting of the Japanese Urological Association and received the Best Post Award!!
Apr. 22, 2024: Akihide Yoshimi gave a lecture at the EPOC/CPOT Seminar Series 5.
Apr. 20, 2024: Akihide Yoshimi gave an invited lecture at the international symposium of the 76th Annual Meeting of the Japan Society of Obstetrics and Gynecology.
Apr. 12, 2024: Muto Tomoya's paper is now available online in Leukemia!
Apr. 3, 2024: Akihide Yoshimi has contributed to the publication ’Recent Trends in Nucleic Acid Medicines: Modalities, Synthesis, Analysis, and DDS’ (in Japanese).
Apr. 1, 2024: Mina Yoshida has become a Japan Society for the Promotion of Science Special Research Fellow (DC2)!
Apr. 1, 2024: Ryoichi Maenosono has been appointed as a research fellow!
Apr. 1, 2024: Akihide Yoshimi has become a Visiting Professor (Affiliated Graduate School) at Keio University School of Medicine.
Apr. 1, 2024: Akihide Yoshimi has become a part-time lecturer (Affiliated Graduate School) at Tokyo Medical and Dental University.
Apr. 1, 2024: Minori Koizumi has just joined as a master's student!
Apr. 1, 2024: Takuya Izumi has officially joined as a graduate student!
Apr. 1, 2024: Hirotaka Matsui has joined the lab as a department head (concurrent position)!
Mar. 22, 2024: Our research proposal, Developing a platform for detecting onco-exaptation and assessing its clinical relevance, has been chosen for funding by AMED. PI: Akihide Yoshimi
Feb. 20, 2024: Rei Kudo and Ryoichi Maenosono presented posters at the NCC Research Meeting for Young Investigators.
Feb. 15, 2024: Ryoichi Maenosono had an oral presentation at the 57th Annual Meeting of Japanese Society for Clinical Renal Transplantation.
Jan. 27, 2024: Tomoya Muto had an oral presentation at the 28th Hematological Malignancy Research Meeting.
Dec. 9, 2023: Tomoya Muto and his teammates presented their poster at The 65th American Society of Hematology Annual Meeting.
Dec. 9, 2023: Rei Kudo delivered an oral presentaion in the spotlight session at SABCS23.
Dec. 8, 2023: The impact of genetic FGFR3 alterations in bladder cancer on the tumor immune microenvironment and the effectiveness of immunotherapy elucidated!! The results of a collaborative study with Osaka Medical and Pharmaceutical University have been published in the Molecular Cancer. Contributors from our lab include Drs. Nishimura K, Ajiro M, Maenosono R, and Yoshimi A (corresponding author).
Dec. 1, 2023: Akihide Yoshimi delivered an invited talk at the 4th Osaka Hematology Meeting.
Nov. 10, 2023: Ryoichi Maenosono had a poster presentation at the 37th Congress of Japanese Society of Endourology and Robotics.
Nov. 1, 2023: Kaori Sakuma has joined our team as a technician!!
Oct. 26, 2023: Junko Mukohyama was awarded the 5th Hiroko Yamamoto Award from the apan Medical Women's Association!
Oct. 21, 2023: Akihide Yoshimi delivered an invited talk at the 61th Annual Meeting of Japanese Society of Clinical Ongology.
Oct. 21, 2023: Kazuki Nishimura had an oral presentation at the 3rd AOS 2023 Meeting.
Oct. 21, 2023: Ryoichi Maenosono had an oral presentation at the 3rd AOS 2023 Meeting.
Oct. 20, 2023: Kazuki Nishimura presented his poster at the 61th Annual Meeting of Japanese Society of Clinical Ongology.
Oct. 16, 2023: Rei Kudo has joined as a project researcher!!
Oct. 15, 2023: Tomoya Muto gave an educational lecture at the 85th Congress of the Japanese Society of Hematology.